For about a month, Professor Bülent Tutluoğlu, a Pulmonologist with Acıbadem Healthcare Group, was battling COVID-19 in the intensive care unit, with a 50% chance of recovery. Over the course of treatment, he was intubated and placed on plasmapheresis or ‘cleaning’ of blood and stem cell therapy. Yet all he could think of was getting back to his patients.
Professor Tutluoğlu was one of the first few physicians who were infected by COVID-19 in Turkey several days after the country recorded its first case on 11 March. He was admitted to the hospital on 17 March, where he was eventually tested COVID-19 positive.
As his condition worsened, he was transferred to the intensive care unit, where he was put on ventilation and started on a challenging treatment involving plasmapheresis and stem cell therapy.
While I was anaesthetised by my colleagues at the intensive care unit, I told myself that I cannot be defeated by this infection,” said the Professor.
After battling the disease for almost a month, he was finally well to go home. As he walked out of the ward, cheered on by well-wishers, his first response when asked what he was looking forward to most, was: “I can go back to treating my patients now!”
Related Stories
IHH Healthcare Deepens Commitment to Reduce Cancer Burden in Malaysia
Learn how our third memorandum of understanding with Ministry of Health Malaysia is expanding access to life-saving, advanced cancer care at 8 of our hospitals.
IHH Healthcare Bags Five Wins at the 15th Asian Excellence Awards
Celebrating our leadership, sustainability, and investor relations excellence on the regional stage.
Fortis CEO Shares Vision for a Healthier India on NDTV
Here is a look at how Fortis is contributing to India’s healthcare transformation.
IHH Singapore Hits New Digital and Imaging Milestones
Across Singapore, IHH Healthcare is transforming care delivery through data, technology and frontline innovation.
Parkway Radiology Deploys Annalise.ai Chest X-ray AI Solution
Parkway Radiology has implemented the Annalise.ai Enterprise CXR solution across all its radiology clinics and hospital departments in Singapore. This represents the first network-wide deployment of the chest X-ray AI technology in the country.
Fortis Enhances Diagnostic and Paediatric Care at S L Raheja Hospital, Mumbai
S L Raheja Hospital, a Fortis Associate, has significantly expanded its diagnostic and paediatric capabilities with the launch of AI-enabled Digital Positron Emission Tomography–Computed Tomography (PET-CT), 3 Tesla Magnetic Resonance Imaging (MRI), and upgraded Neonatal Intensive Care Unit (NICU) and Paediatric Intensive Care Unit (PICU) services.
